Seal of the DOSPC

The Delaware Prescription Opioid Settlement Distribution Commission (POSDC) is an established Subcommittee of the Delaware Behavioral Health Consortium (BHC).  The POSDC is charged with providing funding recommendations to the BHC to abate and remediate Delaware’s Opioid crisis. The recommendations are required to be evidence-based to maximize opportunities to implement effective treatment interventions, recovery supports and prevention services.   

The Commission is currently co-chaired by Delaware’s Lt. Governor Bethany Hall-Long and Attorney General Kathleen Jennings. The work of the POSDC is supported by its co-chairs and the following five standing committees:

The purpose of the POSDC is to abate and remediate the opioid epidemic throughout the State of Delaware through financial support from the Fund in the form of grant awards for efforts to treat, prevent, and reduce opioid use disorder and the misuse of opioids.

 Upcoming October Committee and Commission Meetings

Join Our Mailing List

Sign up to receive the latest POSDC updates.

“As Lt. Governor of Delaware I have focused my time on helping those who are suffering from addiction and mental health challenges. I am thrilled that after years of hard work by Attorney General Jennings we now have access to these settlement funds to provide much needed help to those in Delaware affected by the opioid crisis. As the Chair of the Behavioral Health Consortium which oversees the Prescription Opioid Settlement Distribution Commission (POSDC), I am looking forward to working with our partners to make sure every dollar is used to help build back up the communities who have been most affected.”

Biography – Lieutenant Governor Bethany Hall Long – State of Delaware

Lt. Governor Bethany Hall-Long
Lt. Governor Bethany Hall-Long

“I’m proud of the work that my office has done to hold Big Pharma accountable and to secure significant funds to combat the opioid crisis in Delaware — but securing money is only half the battle. The Prescription Opioid Settlement Distribution Commission is an independent, collaborative group of Delaware leaders, policymakers, and public advocates with one mission: ensuring that the resources from Delaware’s opioid settlements go exactly, and exclusively, where they’re needed. The Commission is more than a steward of a precious public resource; it is a voice for the people of Delaware, who have paid the real price of the opioid crisis.”

Biography – Attorney General Kathy Jennings

Attorney General Kathy Jennings
Headshot of Attorney General Kathy Jennings

Biography – Susan Watson Holloway

Executive Director Susan Watson Holloway, MPA, MS

Susan Watson Holloway


The Behavioral Health Consortium is an advisory body comprised of community advocates, law enforcement, healthcare professionals, and state leaders that works towards solutions for action to address prevention, treatment, and recovery for mental health, substance use, and co-occurring disorders. The consortium continues to develop short-term and long-term strategies and initiatives to address the major addiction and mental health challenges we face in Delaware. Please use the links below to find out more about the work of the consortium.

CLOSED – 2023 PHASE 1B APPLICATION DOCUMENTS

The 2023 Phase 1B Opioid Abatement and Remediation Grant Program is accepting applications from May 15, 2023, through June 18, 2023
Phase 1B 2023 Application Guidelines
Grant Agreement

VIRTUAL GRANT ORIENTATION SESSIONS
Wednesday, May 17, 2023, from 10:00 AM to 11:30 AM
*UPDATED TIME: Wednesday, May 24, 2023, from 11:00 AM to 12:30 AM
Wednesday, May 31, 2023, from 10:00 AM to 11:30 AM

MUNICIPAL & STATE GOVERNMENT APPLICANTS’ VIRTUAL TECHNICAL ASSISTANCE SESSIONS
Beginning Wednesday, May 17th.
Click here for appointments.

GRANT APPLICANTS’ VIRTUAL TECHNICAL ASSISTANCE SESSIONS
Beginning Wednesday, May 17th.
Click here for appointments.

RECORDING – GRANT APPLICATION TECHNICAL ASSISTANCE
POSDC- PHASE 1B 2023 TECHNICAL ASSISTANCE POWERPOINT

CLOSED-2022 PHASE 1A APPLICATION DOCUMENTS

Phase 1A 2022 Application Guidelines
Grant Agreement